We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Veritas Farms Inc (QB) | USOTC:VFRM | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.017885 | 0.0001 | 0.277 | 0.00 | 21:15:12 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 17, 2019
Veritas Farms, Inc. |
(Exact name of registrant as specified in charter) |
Nevada | 333-210190 | 90-1254190 | ||
(State
or other Jurisdiction
of Incorporation) |
(Commission File Number) |
(IRS
Employer
Identification No.) |
1512 E. Broward Blvd., Ste 300, Fort Lauderdale, FL | 33301 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (561) 288-6603
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of Company under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b)) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
None |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
As used in this Current Report on Form 8-K, and unless otherwise indicated, the terms “the Company,” “Veritas Farms,” “we,” “us” and “our” refer to Veritas Farms, Inc. and its subsidiary.
Item 5.03 | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
The disclosure set forth in Item 8.01 of this Current Report on Form 8-K is incorporated into this item by reference.
Item 8.01 | Other Matters. |
Reverse Stock Split
On September 19, 2019, we issued a press release announcing that at the opening of trading on September 20, 2019, we will effect a reverse split of our common stock at a ratio of 1:4.
A copy of the press release is filed as Exhibit 99.1 to this report.
Establishment of Medical Advisory Board
On September 17, 2019, Veritas Farms issued a press release announcing establishment of its Medical Advisory Board to aid in advancing hemp research and new product development.
A copy of the press release is filed as Exhibit 99.2 to this report.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 19, 2019 | VERITAS FARMS, INC. | |
By: | /s/ Alexander M. Salgado | |
Alexander M. Salgado, Chief Executive Officer |
2
1 Year Veritas Farms (QB) Chart |
1 Month Veritas Farms (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions